Myeloablative Fractionated Busulfan, Fludarabine, Cladribine, Thiotepa and Venetoclax (Cladillac) Conditioning Regimen for Allogeneic Stem Cell Transplantation in Very High-Risk AML/MDS: A Phase 2 Trial

This article has no abstract
Epistemonikos ID: 56e173fb724d36555ff1742d134c068439e029b6
First added on: Feb 26, 2025